Derivation of neuroepithelial precursors from embryonic stem (ES) cells using stromal cell-derived inducing activity (SDIA).
Access restricted. Please log in or start a trial to view this content.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments | |
|---|---|---|---|---|
| L-Glutamine | GIBCO, by Life Technologies | 25030 | ||
| alpha-MEM | GIBCO, by Life Technologies | 12571 | ||
| Penicillin/streptomycin | GIBCO, by Life Technologies | 15140 | ||
| Knockout-DMEM | GIBCO, by Life Technologies | 10829 | ||
| Knockout serum replacement | GIBCO, by Life Technologies | 10828 | ||
| MEM nonessential amino acid solution | GIBCO, by Life Technologies | 12383 | ||
| DMEM/F12 | GIBCO, by Life Technologies | 11330 | ||
| N2-A supplement | Stem Cell Technologies | 07152 | ||
| Mitomycin-C | Sigma-Aldrich | M0503 | ||
| Gelatine type-A | Sigma-Aldrich | G1890 | ||
| poly-L-ornithine | Sigma-Aldrich | P4957 | 0.01% solution | |
| Laminin | Sigma-Aldrich | L-2020 | ||
| Fibronectin | Sigma-Aldrich | F2006 | ||
| Basic fibroblast growth factor (bFGF) | Invitrogen | 13256 | ||
| 1 mL Syringe with 27 1/2 G needle | BD Biosciences | 309623 | ||
| N2-A media | medium | DMEM/F12 + 1% N2-A supplement | ||
| Serum replacement media (SRM) | medium | Knockout-DMEM + 20% Knockout serum replacement +1% MEM nonessential amino acid solution + 2 mM L-glutamine | ||
| α-MEM media | medium | α-MEM + 10% FBS + 2 mM L-glutamine + 1% penicillin/streptomycin | ||
| MS5 | cell line | stromal cells | ||
| Microscope | ||||
| 6-well Plates | for tissue culture |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission